Kalamazoo, Michigan-based Stryker touts its limited-market release, patient-matched primary reversed glenoid as the first surgeon-driven, primary patient-specific implant available in shoulder arthroplasty. The company planned the implant on its Blueprint 3D planning software.
According to a news release, Dr. Jay Keener of St. Louis completed the first implant on Jan. 13, 2022. It will be highlighted in a presentation at the 2022 Advanced Shoulder Arthroplasty (ASAP) Meeting on Jan. 21 in Snowbird, Utah.
“The patient-matched glenoid puts surgeons in the driver’s seat to contour the implant to the face of the native glenoid that is unique to each patient’s anatomy,” Dr. George S. Athwal, one of the designers of the implant system, said in the release. “The patient-matched glenoid system increases efficiency in the OR, requiring fewer surgical steps and no glenoid bone reaming.”
Stryker’s Blueprint software allows a surgeon to virtually position and execute the creation of a patient-matched implant. Once completed in Blueprint, an order is generated to manufacture the glenoid baseplate and patient-specific instrumentation before the surgeon receives the sterile devices and executes the implantation of the baseplate through a ream-free, bone-preserving technique.
“Stryker’s relentless pursuit of innovation is exemplified in the Patient-Matched Glenoid, a strong addition to our upper extremities portfolio,” Stryker VP & GM of Upper Extremities Tim Lanier said. “It will give our customers autonomy that is not available anywhere else in the market.”
